Twist Bioscience (TWST -3.3%) has added four new synthetic SARS-CoV-2 controls to its offering that include new variants of the coronavirus.
It launched its first two controls in March.
Controls are used in the development and validation of diagnostic tests.
https://seekingalpha.com/news/3582295-twist-bio-expands-offering-of-synthetic-coronavirus-controls
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.